Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
biotech
3
×
boston blog main
boston top stories
inclisiran
life sciences
national blog main
national top stories
3
×
new york blog main
new york top stories
pcsk9
regeneron pharmaceuticals
alirocumab
boulder/denver blog main
boulder/denver top stories
cholesterol
detroit blog main
detroit top stories
evolocumab
indiana blog main
indiana top stories
medco
medicines co.
national
praluent
raleigh-durham blog main
raleigh-durham top stories
repatha
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
sanofi
seattle blog main
seattle top stories
texas blog main
texas top stories
trial
wisconsin blog main
wisconsin top stories
What
cholesterol
3
×
drug
new
wave
abbvie’s
acquire
agreed
barbecuing
billion
bio
brings
camping
cardiologist
cash
center
check
company
compound
conference
day
deal
drugs
expensive
faces
fda
financial
flop
foe
healthcare
hint
hit
inhibitors
j
j’s
known
labor
lowering
medco
medicines
monday
Language
unset
Current search:
cholesterol
×
biotech
×
" national top stories "
×
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)